Retraction statement: Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).
Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH. Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). J Dermatol 2018; 45: 309-313. The above article, first published online on 5 October 2017 in Wiley Online Library (http://wileyonlinelibrary.com) has been retracted by agreement between the authors, the Journal Editor-in-Chief, Masutaka Furue, and John Wiley & Sons Australia, Ltd. The Retraction has been agreed due to an error in Table 3. The estimate for 'Smoke (yes vs no)' should have been a positive value. The baseline serum triglyceride level of psoriasis patients that are smokers was not higher than that of non-smokers. However, after treatment, the triglyceride level of psoriasis patients that are non-smokers increased more tremendously than that of psoriasis patients that are smokers. Reference 1 Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH. Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). J Dermatol 2018; 45: 309-313.